KIM
IBB icon

Kestra Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Kestra Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53
Closed -$6.94K – 1151
2024
Q4 		$6.94K Buy
+53
New +$7.45K ﹤0.01% 865

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Kestra Investment Management's IBB Position: Q1 2025 in Review

Kestra Investment Management sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 53 shares — an estimated $6.94K sold.

Kestra Investment Management first reported a position in IBB in Q4 2024 and held it in 1 quarter. The position peaked at $6.94K in Q4 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Kestra Investment Management reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Kestra Investment Management sold 53 iShares Biotechnology ETF shares in Q1 2025, an estimated $6.94K.
  • Kestra Investment Management first reported a position in iShares Biotechnology ETF in Q4 2024 and held it in 1 quarter.
  • Kestra Investment Management's iShares Biotechnology ETF position peaked at $6.94K in Q4 2024.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Kestra Investment Management's 13F filing for Q1 2025, filed 16 May 2025.